Skip to main content

Advertisement

Log in

The drug resistance-related protein LRP is the human major vault protein

  • Article
  • Published:

From Nature Medicine

View current issue Submit your manuscript

Abstract

Multidrug-resistant cancer cells frequently overexpress the 110-kD LRP protein (originally named Lung Resistance-related Protein). LRP overexpression has been found to predict a poor response to chemotherapy in acute myeloid leukaemia and ovarian carcinoma. We describe the cloning and chromosome localization of the gene coding for this novel protein. The deduced LRP amino acid sequence shows 87.7% identity with the 104-kD rat major vault protein. Vaults are multi-subunit structures that may be involved in nucleo-cytoplasmic transport. The LRP gene is located on chromosome 16, close to the genes coding for multidrug resistance-associated protein and protein kinase C-β, and may mediate drug resistance, perhaps via a transport process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Roninson, I.B. Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells.(Plenum, New York, 1991).

    Book  Google Scholar 

  2. Endicott, J.A. & Ling, V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58, 137–171 (1989).

    Article  CAS  Google Scholar 

  3. Cole, S.P.C. et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 258, 1650–1654 (1992).

    Article  CAS  Google Scholar 

  4. Zaman, G.J.R. et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. natn. Acad. Sci. U.S.A. 91, 8822–8826 (1994).

    Article  CAS  Google Scholar 

  5. Futscher, B.W., Abbaszadegan, M.R., Domann, F. & Dalton, W.S. Analysis of MRP mRNA in mitoxantrone-selected, multidrug-resistant human tumor cells. Biochem. Pharmacol. 47, 1601–1606 (1994).

    Article  CAS  Google Scholar 

  6. Takeda, Y. et al. Reversal of multidug resistance by tyrosine-kinase inhibitors in a non-P-glycoprotein-mediated multidrug-resistant cell line. Int. J. Cancer. 57, 229–239 (1994).

    Article  CAS  Google Scholar 

  7. Slapak, C.A. et al. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin selected multidrug-resistant murine erythroleukemia cells. Cancer Res. 54, 5607–5613 (1994).

    CAS  PubMed  Google Scholar 

  8. Scheper, R.J. et al. Overexpression of a M (r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res. 53, 1475–1479 (1993).

    CAS  PubMed  Google Scholar 

  9. List, A.F. et al. Non-P-glycoprotein (Pgp) mediated multidrug resistance (MDR): Identification of a novel drug resistance phenotype with prognostic relevance in acute myeloid leukemia (AML). Blood. 82, (suppl. 1) 443a (1993).

    Google Scholar 

  10. Izquierdo, M.A. et al. Prognostic significance of the drug resistance associated protein LRP in advanced ovarian carcinoma. Ann. Oncol. 5, (suppl. 8), 98 (1994).

    Google Scholar 

  11. Kickhoefer, V.A. & Rome, L.H. The sequence of a cDNA encoding the major vault protein from Rattus norvegicus . Gene. 151, 257–260 (1994).

    Article  CAS  Google Scholar 

  12. Vasu, S.K., Kedersha, N.L. & Rome, L.H. cDNA cloning and disruption of the major vault protein alpha gene (mvpA) in Dictyostelium discoideum . J. biol. Chem. 268, 15356–15360 (1993).

    CAS  PubMed  Google Scholar 

  13. Kedersha, N.L. & Rome, L.H. Isolation and characterization of a novel ribonucleoprotein particle: Large structures contain a single species of small RNA. J. cell Biol. 103, 699–709 (1986).

    Article  CAS  Google Scholar 

  14. Rome, L.H., Kedersha, N.L. & Chugani, D.C. Unlocking vaults: Organelles in search of a function. Trends Cell Biol. 1, 47 (1991).

    Article  CAS  Google Scholar 

  15. Kedersha, N.L., Miquel, M.C., Bittner, D. & Rome, L.H. Vaults II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes. J. cell Biol. 110, 895–901 (1990).

    Article  CAS  Google Scholar 

  16. Wu, L. et al. Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening. Cancer Res. 52, 3029–3034 (1992).

    CAS  PubMed  Google Scholar 

  17. Slovak, M.L. et al. Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines. Cancer Res. 53, 3221–3225 (1993).

    CAS  PubMed  Google Scholar 

  18. Francke, U., Yang Feng, T.L., Brissenden, J.E. & Ullrich, A. Chromosomal mapping of genes involved in growth control. Cold Spring Harb. Symp. quant. Biol. 51, 855–866 (1986).

    Article  CAS  Google Scholar 

  19. Chambers, T.C., Zheng, B. & Kuo, J.F. Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells. Molec. Pharmacol. 41, 1008–1015 (1992).

    CAS  Google Scholar 

  20. Kuss, B.J. et al. Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: Prognostic implications. Lancet. 343, 1531–1534 (1994).

    Article  CAS  Google Scholar 

  21. Chugani, D.C., Rome, L.H. & Kedersha, N.L. Evidence that vault ribonucleo-protein particles localize to the nuclear pore complex. J. cell Sci. 106, 23–29 (1993).

    CAS  PubMed  Google Scholar 

  22. Rout, M.P. & Wente, S.R. Pores for thought: Nuclear pore complex proteins. Trends cell Biol. 4, 357–365 (1994).

    Article  CAS  Google Scholar 

  23. Schuurhuis, G.J. et al. Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein. Br. J. Cancer. 64, 857–861 (1991).

    Article  CAS  Google Scholar 

  24. Dietel, M., Arps, H., Lage, H. & Niendorf, A. Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257. Cancer Res. 50, 6100–6106 (1990).

    CAS  PubMed  Google Scholar 

  25. Slovak, M.L., Hoeltge, G.A., Dalton, W.S. & Trent, J.M. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines. Cancer Res. 48, 2793–2797 (1988).

    CAS  PubMed  Google Scholar 

  26. Zijlstra, J.G., de Vries, E.G.E. & Mulder, N.H. Multifactorial drug resistance in an Adriamycin-resistant human small-cell lung carcinoma cell line. Cancer Res. 47, 1780–1784 (1987).

    CAS  PubMed  Google Scholar 

  27. Kuiper, C.M. et al. Drug transport variants without P-glycoprotein Overexpression from a human squamous lung cancer cell line after selection with doxorubicin. J. Cell Pharm. 1, 35–4l (1990).

    CAS  Google Scholar 

  28. Eva, A. et al. Cellular genes analogous to retroviral one genes are transcribed in human tumour cells. Nature. 295, 116 (1982).

    Article  CAS  Google Scholar 

  29. Muller, W.J., Naujokas, M.A. & Hassell, J.A. Isolation of large T antigen-producing cell lines capable of supporting replication of polyomavirus-plasmid recombinants. Molec. cell. Biol. 4, 2406–2412 (1984).

    Article  CAS  Google Scholar 

  30. Wijngaard, P.L.J., Metzelaar, M.J., McHugh, N.D., Morrison, W.I. & Clevers, H.C. Molecular characterization of the WC1 antigen expressed specifically on bovine CD4− CD8− gamma delta T lymphocytes. J. Immun. 149, 3273–3277 (1992).

    CAS  PubMed  Google Scholar 

  31. Aruffo, A. & Seed, B. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. natn. Acad. Sci. U.S.A. 84, 8573–8577 (1987).

    Article  CAS  Google Scholar 

  32. Sanger, F., Nicklen, S. & Coulson, A.R. DNA sequencing with chain-terminating inhibitors. Proc. natn. Acad. Sci. U.S.A. 74, 5463–5467 (1977).

    Article  CAS  Google Scholar 

  33. Zinn, K., Dimaio, D. & Maniatis, T. Identification of two distinct regulatory regions adjacent to the human beta-interferon gene. Cell. 34, 865–879 (1983).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scheffer, G., Wijngaard, P., Flens, M. et al. The drug resistance-related protein LRP is the human major vault protein. Nat Med 1, 578–582 (1995). https://doi.org/10.1038/nm0695-578

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0695-578

  • Springer Nature America, Inc.

This article is cited by

Navigation